Abstract
Objective To investigate the treatment ways of the chronic hepatitis B virus(HBV)carriers.Methods To drink oral solution of Lamivudine Joint P-transfer factor treatment for HBV carriers HBeAg,anti-HBc-IgM,HBVDNA were 75 cases positive for the observation group,38 cases were control group,only lamivudine service and observed for6-12 months.Results The treatment of 6 months observation group HBeAg,anti-HBe,HBVDNA conversion of 47.9%,15.4% and 78.9%;control group was 28.8%,13.8% and 68.1%;the treatment of 12 months,the Observer Group of HBeAg,antiHBe,HBVDN A conversion of 64.8%,36.7% and 82.3%;control group was 36.6%,13.8% and 68.2%.Comparing the two groups,there was a significant difference(P＜0.Q5).Conclusions Oral solution of P-transfer factor can improve the carriers of HBV lamivudine biochemistry,serological response rate,the two joint is a better anti-HBV treatment. Key words: P-transfer factor lamivudine; hepatitis B; chronic
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
